Gemcitabine in heavily pretreated adult soft tissue sarcoma patients

被引：0
|
作者：
Schoeler, D. [1 ]
Kunitz, A. [1 ]
Reichardt, P. [1 ]
机构：
[1] Charite Campus Virchow Klinikum, Berlin, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
20524
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Combination of trastuzumab and gemcitabine as salvage therapy in heavily pretreated patients with metastatic breast cancer
    Bartsch, R.
    Wenzel, C.
    Pluschnig, U.
    Altorjai, G.
    Dubsky, P.
    Scheurer, R.
    Rottenfusser, A.
    Gnant, M.
    Zielinski, C. C.
    Steger, G. G.
    EJC SUPPLEMENTS, 2008, 6 (07): : 178 - 179
  • [32] Effect of weekly administration of bevacizumab, gemcitabine, and oxaliplatin in patients with heavily pretreated ovarian cancer
    Ikeda, Yuji
    Kikuchi, Yoshihiro
    Takano, Masashi
    Goto, Tomoko
    Kouta, Hiroko
    Sasaki, Naoki
    Kudoh, Kazuya
    Oda, Katsutoshi
    Nagasaka, Tsuneki
    Kita, Tsunekazu
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [33] Gemcitabine, etoposide and dexamethasone in the treatment of heavily pretreated patients with non Hodgkin's lymphoma
    Spectre, G
    Goldchmidt, N
    Gural, A
    Paltiel, O
    Ben-Yehuda, D
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 605S - 605S
  • [34] Gemcitabine and Docetaxel for Metastatic Soft Tissue Sarcoma - a Single Center Experience
    Schmitt, Thomas
    Kosely, Florentina
    Wuchter, Patrick
    Schmier, Johann-Wilhelm
    Ho, Anthony D.
    Egerer, Gerlinde
    ONKOLOGIE, 2013, 36 (7-8): : 415 - 420
  • [35] Pharmacogenetics of doxorubicin, gemcitabine and docetaxel in the GeDDiS soft tissue sarcoma trial
    Jamieson, David
    Seddon, Beatrice
    Kuever, Katja
    Dehbi, Hakim-Moulay
    Strauss, Sandra
    Beare, Sandy
    Veal, Gareth
    CANCER RESEARCH, 2017, 77
  • [36] Incidence of multiple primary malignancies in a cohort of adult patients with soft tissue sarcoma
    Tateishi, U
    Hasegawa, T
    Yamamoto, S
    Yamaguchi, U
    Yokoyama, R
    Kawamoto, H
    Satake, M
    Arai, Y
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 35 (08) : 444 - 452
  • [37] Weekly Gemcitabine and Docetaxel in Refractory Soft Tissue Sarcoma: A Retrospective Analysis
    Lee, Ha-young
    Shin, Sang Joon
    Kim, Hyo Song
    Hong, Soo Jung
    Han, Jung Woo
    Lim, Seung Taek
    Roh, Jae Kyung
    Rha, Sun Young
    CANCER RESEARCH AND TREATMENT, 2012, 44 (01): : 43 - 49
  • [38] The relationship between pretreatment anaemia and survival in patients with adult soft tissue sarcoma
    Nakamura, Tomoki
    Grimer, Robert
    Gaston, Czar
    Carter, Simon
    Tillman, Roger
    Abudu, Adesegun
    Jeys, Lee
    Sudo, Akihiro
    JOURNAL OF ORTHOPAEDIC SCIENCE, 2013, 18 (06) : 987 - 993
  • [39] Exatecan (DX-8951f), a new topoisomerase I-inhibitor, is inactive in heavily pretreated patients (pts.) with advanced soft tissue sarcoma (STS):: A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group.
    Pink, D
    Reichardt, P
    Nielsen, S
    Bauer, S
    Hartmann, JT
    Schöffski, P
    van Oosterom, AT
    Daugaard, S
    Stoichkov, K
    Hermans, C
    Judson, IR
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 830S - 830S
  • [40] Trabectedin in heavily pretreated and elderly metastatic soft tissue sarcomas - a single center experience
    Hoiczyk, M.
    Grabellus, F.
    Taeger, G.
    Schuler, M.
    Bauer, S.
    ONKOLOGIE, 2011, 34 : 237 - 237
12345